Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 273-729-7 | CAS number: 69012-29-9 By-product from the production of ferronickel from a complex ore. Consists primarily of oxides of aluminum, iron, magnesium and silicon.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Ames test was performed on five S typhimurium strains (TA 98, TA 100, TA1535, TA1537 and TA102) with or without metabolic activation according to OECD 471. The test item was diluted either in 0.9% NaCl in water ir in DMSO to final concentrations of 10, 20, 40, 60, 80 and 100%. No toxic effects were noted in all tester strains at all concentrations in experiment I (with Aqua dest) and in experiment II (with DMSO). No biologically relevant increase in revertant colonies were observed following treatment with polar or non-polar extracts of the test item at any concentration level neither in the presence or absence of metabolic activation. The reference mutagens caused a distinct increase confirming the validity of the experiment. It can be deduced that the test item is not mutagenic for bacteria under the present experimental conditions.
A test item extract of Slags, ferronickel-manufg./Electric Furnace Slag/ Converter Slag was investigated for a possible potential to induce micronuclei in Chinese hamster V79 cells in vitro in the absence and presence of metabolic activation with S9.
The test item was extracted in cell culture medium at a weight/volume ratio of 0.2 g/mL for 72 h ( 2 h) at 37 °C ( 1 °C) according to ISO 10993-3, 2003 and ISO 10993-12, 2007. The extract was centrifuged at room temperature for 5 minutes at 1000 g. The test item extract was diluted in cell culture medium prior to treatment and the pH of the solution was adjusted to 7.0.
In experiment I with and without metabolic activation 100% Extract was selected as highest dose group for the microscopic analysis of micronuclei.
In experiment II without metabolic activation 80% Extract was selected as highest dose group for the microscopic analysis of micronuclei. The following concentrations were evaluated:
Experiment I with short exposure (4 h):
with and without metabolic activation: 60, 80 and 100%
Experiment II with extended exposure (24 h):
without metabolic activation: 20, 40, 60 and 80%
In the main experiment I with and without metabolic activation no biologically relevant increase of the micronucleus frequency was noted after treatment with an extract of the test item. In the main experiment II without metabolic activation no biologically relevant increase of the micronucleus frequency was noted after treatment with an extract of the test item.
The nonparametric test was performed to verify the results in both experiments. No statistically significant enhancement (p<0.05) of cells with micronuclei was noted in the dose groups of the test item extract evaluated, except for the test item extract concentrations of 20% and 60% in experiment II without metabolic activation. These values were significantly increased compared to the corresponding negative control. However, the micronucleus frequencies were within the historical control data range of the negative control and no dose-response relationship could be observed.
Based on these data, the number of micronucleated cells found in the groups treated with the test item did not show a biologically relevant increase as compared to the corresponding negative control.
Ethylmethanesulfonate (EMS, 900 and 600 μg/mL) and Cyclophosphamide (CPA, 2.5 μg/mL) were used as clastogenic controls. Colcemide (0.08-0.8 μg/mL) was used as aneugenic control. All induced distinct and biologically relevant increases of micronucleus frequency. This demonstrates the validity of the assay.
The fine particle fraction of various grades of Ferronickel Slags was analysed with XRD using Rietveld quantitative phase analysis to determine the respirable crystalline silica (RCS) content. As a result no RCS was detected, so it is safely assumed that the SiO2 in the substance is amorphous.
The chromium species were determined via XRD analysis. No hexavalent Chromium species were present up to the limit of detection of the analytical method (20mg/kg) so all Cr in the substance is considered to be in trivalent form.
Short description of key information:
Slags, ferronickel-manufg was found to be non-mutagenic for bacteria in an OECD 471 bacteria reverse mutation test and did not induce structural and/or numerical chromosomal damages, in an OECD 487 In vitro Micronucleous Test, in Chinese hamster V79 cells.Therefore, an extract of Slags, ferronickel-manufg is considered to be non-mutagenic.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Slags, ferronickel-manufg was found to be non-mutagenic for bacteria in an OECD 471 bacteria reverse mutation test and did not induce structural and/or numerical chromosomal damages, in an OECD 487 In vitro Micronucleous Test, in Chinese hamster V79 cells.Therefore, an extract of Slags, ferronickel-manufg is considered to be non-mutagenic and, therefore, no classification in regards to its mutagenicity is required, according to the CLP regulation.
Furthermore, no Respirable Crystalline Silica (RCS) or hexavalent Chromium was detected in analyses via XRD with Rietveld analysis and colorimetry after digestion, respectively, so no genetic toxicity can occur from these factors.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
